Temple University Hospital Adopts Masimo Centroid™
Premier Philadelphia Academic Medical Center Implements Advanced Masimo Wearable, Wireless Patient Position, Orientation, and Activity Sensors in its ICUs PHILADELPHIA--(BUSINESS...
Year: 2022
Industry-Pioneer Savage Enterprises Signs Letter of Intent to Purchase Additional 47% Stake in Wyoming Based Company, Remediez
IRVINE, CA / ACCESSWIRE / February 7, 2021 / Award-winning e-liquid and cannabinoid-infused products manufacturer Savage Enterprises ("Savage") (www.SavageEnterprises.com) announced...
Impact Fusion International Aims to be a Disruptor in the Cattle Feed Industry
NAPOLEONVILLE, LA / ACCESSWIRE / February 7, 2022 / Impact Fusion International, Inc. (OTC PINK:IFUS)Letter to Our Shareholders:Our premier product,...
ONWARD Medical’s Technology Enables Walking and Standing After Severe Spinal Cord Injuries
STIMO-BRIDGE Study Results Published in Nature Medicine EINDHOVEN, Netherlands & LAUSANNE, Switzerland--(BUSINESS WIRE)--THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE...
epocrates Doubles Down on Commercial Business in 2022, Plans to Continue Aggressive Growth Strategy in Evolving Pharmaceutical Industry
Bolsters executive leadership with addition of chief commercial officer, Matt Titus, to lead next phase of business expansion WATERTOWN, Mass.--(BUSINESS...
Altamira Therapeutics and Avernus Pharma Collaborate for Marketing and Distribution of Bentrio in Gulf Countries
HAMILTON, BERMUDA / ACCESSWIRE / February 7, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that...
Goodbody Health Announces Extension of Scope of ISO 17025
VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased...
NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022
Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled21 clinical sites in the...
Net Medical Begins Covid Testing on Behalf of New Mexico Department of Health
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and...
CytomX Therapeutics Announces Promotion of Amy C. Peterson, M.D. to President and Chief Operating Officer
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Milestone Scientific to Present at MicroCap Rodeo’s Winter Wonderland Best Ideas Conference on Wednesday, February 9
ROSELAND, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Optimi Health Dealer’s License Granted by Health Canada
Optimi Health to become a global leader in all-natural psilocybin productionVANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Optimi...
Revelation Biosciences Inc. to Present at 2022 BIO CEO & Investor Conference
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life...
BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway
BioRestorative Provides Update on its Active Phase 2 Clinical Trial MELVILLE, N.Y., Feb. 07, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
Denali Therapeutics Announces Appointment of Erik Harris to Board of Directors
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
Allied Corp Signs Sales Order for 1000kgs Worth One Million Euros of Cannabis Flower
KELOWNA, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Acarix invites to virtual Capital Market Day
Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercialization and focus...
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts
BURBANK, CA, Feb. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing,...
Actuate Therapeutics Announces Initiation of a Multicenter Randomized Trial of Elraglusib Plus FOLFIRINOX As First Line Therapy for Advanced Pancreatic Cancer
Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General...
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
SUWON, Republic of Korea, Feb. 07, 2022 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...